An Economic Evaluation of Valsartan for Post-MI Patients in the UK Who Are Not Suitable for Treatment with ACE Inhibitors

Abstract Objectives The overall objective of this study was to estimate the costs and outcomes associated with treatment with valsartan for post-myocardial infarction (post-MI) patients with left ventricular systolic dysfunction, heart failure, or both, who are not suitable for treatment with angiot...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2009-06, Vol.12 (4), p.459-465
Hauptverfasser:	Taylor, Matthew, PhD, Scuffham, Paul A., PhD, Chaplin, Stephen, BSc, Papo, Natalie L., MSc
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin II Type 1 Receptor Blockers - economics Angiotensin II Type 1 Receptor Blockers - therapeutic use Angiotensin-Converting Enzyme Inhibitors - economics Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - economics Antihypertensive Agents - therapeutic use cardiovascular disease Cost effectiveness Cost-Benefit Analysis Data Collection Decision Making economic Health costs Health status Heart failure Humans Internal Medicine Kaplan-Meier Estimate Marketing Markov Chains Models, Economic Models, Statistical Myocardial infarction Myocardial Infarction - drug therapy Myocardial Infarction - economics Psychometrics Quality adjusted life years stroke Tetrazoles - economics Tetrazoles - therapeutic use Time Factors United Kingdom Valine - analogs & derivatives Valine - economics Valine - therapeutic use Valsartan
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!